Table of Contents
ISRN Anesthesiology
Volume 2011 (2011), Article ID 402906, 10 pages
http://dx.doi.org/10.5402/2011/402906
Review Article

Mechanism of Anesthetic Toxicity: Metabolism, Reactive Oxygen Species, Oxidative Stress, and Electron Transfer

1Department of Chemistry and Biochemistry, San Diego State University, San Diego, CA 92182, USA
2Centro de Graduados e Investigación del Instituto Tecnológico de Tijuana, Apdo postal 1166, 22500 Tijuana BC, Mexico

Received 13 September 2011; Accepted 11 October 2011

Academic Editors: D. Karakitsos and A. Mizutani

Copyright © 2011 Peter Kovacic and Ratnasamy Somanathan. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Kovacic and R. Somanathan, “Novel, unifying mechanism for aromatic primary-amines (therapeutics, carcinogens and toxins): electron transfer, reactive oxygen species, oxidative stress and metabolites,” MedChemComm, vol. 2, no. 2, pp. 106–112, 2011. View at Publisher · View at Google Scholar
  2. P. Kovacic and J. D. Jacintho, “Reproductive toxins: pervasive theme of oxidative stress and electron transfer,” Current Medicinal Chemistry, vol. 8, no. 7, pp. 863–892, 2001. View at Google Scholar · View at Scopus
  3. P. Kovacic, A. Sacman, and M. Wu-Weis, “Nephrotoxins: widespread role of oxidative stress and electron transfer,” Current Medicinal Chemistry, vol. 9, no. 8, pp. 823–847, 2002. View at Google Scholar · View at Scopus
  4. G. Poli, K.H. Cheeseman, M. U. Dianzani, and T. F. Slater, Free radicals in the Pathogenesis of Liver Injury, Pergmon Press, New York, NY, USA, 1989.
  5. P. Kovacic and L. A. Thurn, “Cardiovascular toxicity from the perspective of oxidative stress, electron transfer, and prevention by antioxidants,” Current Vascular Pharmacology, vol. 3, no. 2, pp. 107–117, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Kovacic and R. Somanathan, “Neurotoxicity: the broad framework of electron transfer, oxidative stress and protection by antioxidants,” Current Medicinal Chemistry - Central Nervous System Agents, vol. 5, no. 4, pp. 249–258, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Kovacic, R. S. Pozos, R. Somanathan, N. Shangari, and P. J. O'Brien, “Mechanism of mitochondrial uncouplers, inhibitors, and toxins: focus on electron transfer, free radicals, and structure-activity relationships,” Current Medicinal Chemistry, vol. 12, no. 22, pp. 2601–2623, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Kovacic and A. L. Cooksy, “Unifying mechanism for toxicity and addiction by abused drugs: electron transfer and reactive oxygen species,” Medical Hypotheses, vol. 64, no. 2, pp. 357–366, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. P. Kovacic and R. Somanathan, “Integrated approach to immunotoxicity: electron transfer, reactive oxygen species, antioxidants, cell signaling, and receptors,” Journal of Receptors and Signal Transduction, vol. 28, no. 4, pp. 323–346, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. P. Kovacic and R. Somanathan, “Pulmonary toxicity and environmental contamination: radicals, electron transfer, and protection by antioxidants,” Reviews of Environmental Contamination and Toxicology, vol. 201, pp. 41–69, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Kovacic and R. Somanathan, “Dermal toxicity and environmental contamination: electron transfer, reactive oxygen species, oxidative stress, cell signaling, and protection by antioxidants,” Reviews of Environmental Contamination and Toxicology, vol. 203, pp. 119–138, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Kovacic and R. Somanathan, “Ototoxicity and noise trauma: electron transfer, reactive oxygen species, cell signaling, electrical effects, and protection by antioxidants: Practical medical aspects,” Medical Hypotheses, vol. 70, no. 5, pp. 914–923, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. P. Kovacic and R. Somanathan, “Unifying mechanism for eye toxicity: electron transfer, reactive oxygen species, antioxidant benefits, cell signaling and cell membranes,” Cell Membranes and Free Radical Research, vol. 1, pp. 56–69, 2008. View at Google Scholar
  14. P. Kovacic and C. Edwards, “Integrated approach to the mechanisms of thyroid toxins: electron transfer, reactive oxygen species, oxidative stress, cell signaling, receptors, and antioxidants,” Journal of Receptors and Signal Transduction, vol. 30, no. 3, pp. 133–142, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. P. Kovacic and J. D. Jacintho, “Mechanisms of carcinogenesis: focus on oxidative stress and electron transfer,” Current Medicinal Chemistry, vol. 8, no. 7, pp. 773–796, 2001. View at Google Scholar · View at Scopus
  16. B. Halliwell and J. M. C. Gutteridge, Free Radicals in Biology and Medicine, Oxford University Press, New York, NY, USA, 1999.
  17. B. K. Park, N. R. Kitteringham, and P. M. O'Neill, “Metabolism of fluorine-containing drugs,” Annual Review of Pharmacology and Toxicology, vol. 41, pp. 443–470, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. B. Halliwell and J. M. C. Gutteridge, Free radicals in Biology and Medicine, Oxford University Press, New York, NY, USA, 2000.
  19. M. Morio, O. Yuge, and K. Fujii, “Biotransformation and toxicity of inhalational anaesthetics,” Canadian Journal of Anaesthesia, vol. 37, no. 1, pp. Scxvi–Scxxiii, 1990. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Tsuchiya, E. Okimasu, W. Ueda, M. Hirakawa, and K. Utsumi, “Halothane, an inhalation anesthetic, activates protein kinase C and superoxide generation by neutrophils,” FEBS Letters, vol. 242, no. 1, pp. 101–105, 1988. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Cox, R. DeRienz, R. A. J. Phipps, B. Levine, A. Jacobs, and D. Fowler, “Distribution of ether in two postmortem cases,” Journal of Analytical Toxicology, vol. 30, no. 8, pp. 635–637, 2006. View at Google Scholar · View at Scopus
  22. C. P. Chengelis and R. A. Neal, “Microsomal metabolism of diethyl ether,” Biochemical Pharmacology, vol. 29, no. 2, pp. 247–248, 1980. View at Publisher · View at Google Scholar · View at Scopus
  23. R. A. Peters and M. Shorthouse, “An alkyl etherase in rat liver,” Journal of Physiology, vol. 252, no. 2, pp. 537–545, 1975. View at Google Scholar · View at Scopus
  24. S. Awasthi, P. Kakkar, P. N. Viswanathan, and R. Bharadwaj, “Effect of anaesthetic ether on lipid peroxidation and superoxide dismutase isozymes of young and adult rat brain,” Indian Journal of Experimental Biology, vol. 27, no. 7, pp. 647–649, 1989. View at Google Scholar · View at Scopus
  25. K. Kumamoto, T. Hirai, S. Kishioka, and H. Iwahashi, “Identification of 1-ethoxyethyl radicals in the reaction of ferrous ions with serums from rats exposed to diethyl ether,” Toxicology Letters, vol. 154, no. 3, pp. 235–239, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. E. D. Kharasch, “Metabolism and toxicity of the new anesthetic agents,” Acta Anaesthesiologica Belgica, vol. 47, no. 1, pp. 7–14, 1996. View at Google Scholar · View at Scopus
  27. M. Hong, M. K. Choi, and J. Lee, “The anesthetic action of ethanol analyzed by genetics in Caenorhabditis elegans,” Biochemical and Biophysical Research Communications, vol. 367, no. 1, pp. 219–225, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. C. J. Fox, H. Liu, and A. D. Kaye, “The anesthetic implications of alcoholism,” International Anesthesiology Clinics, vol. 49, no. 1, pp. 49–65, 2011. View at Publisher · View at Google Scholar · View at PubMed
  29. B. Wolfson and B. Freed, “Influence of alcohol on anesthetic requirements and acute toxicity,” Anesthesia and Analgesia, vol. 59, no. 11, pp. 826–830, 1980. View at Google Scholar · View at Scopus
  30. P. Kovacic and R. Somanathan, “Alcohol mechanism: metabolism, cell signaling, toxicity, addiction, prevention, therapy, and beneficial effects,” in New Research on Alcohol Abuse and Alcoholism, E. Y. Brozner, Ed., chapter 4, pp. 49–102, Nova Science Publishers, New York, NY, USA, 2006. View at Google Scholar
  31. P. Kovacic and R. Somanathan, “Novel, unifying mechanism for mescaline in the central nervous system: electrochemistry, catechol redox metabolite, receptor, cell signaling and structure activity relationships,” Oxidative Medicine and Cellular Longevity, vol. 2, no. 4, pp. 181–190, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. P. Kovacic, “Unifying electron transfer mechanism for psilocybin and psilocin,” Medical Hypotheses, vol. 73, no. 4, pp. 626–631, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. P. Kovacic, “Unifying electron transfer mechanism for addiction involvement by the anesthetic propofol,” Medical Hypotheses, vol. 74, no. 1, p. 206, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. P. Favetta, J. Guitton, C. S. Degoute, L. Van Daele, and R. Boulieu, “High-performance liquid chromatographic assay to detect hydroxylate and conjugate metabolites of propofol in human urine,” Journal of Chromatography B, vol. 742, no. 1, pp. 25–35, 2000. View at Publisher · View at Google Scholar
  35. M. T. Baker, M. S. Gregerson, S. M. Martin, and G. R. Buettner, “Free radical and drug oxidation products in an intensive care unit sedative: propofol with sulfite,” Critical Care Medicine, vol. 31, no. 3, pp. 787–792, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. T. G. Short and Y. Young, “Toxicity of intravenous anaesthetics,” Best Practice and Research: Clinical Anaesthesiology, vol. 17, no. 1, pp. 77–89, 2003. View at Publisher · View at Google Scholar
  37. P. W. Crawford, P. Kovacic, N. W. Gilman, and M. D. Ryan, “Charge transfer mechanism for benzodiazepine (BZ) action. Correlation of reduction potential of BZ iminium with structure and drug activity,” Bioelectrochemistry and Bioenergetics, vol. 16, no. 3, pp. 407–426, 1986. View at Google Scholar · View at Scopus
  38. A. Kohjitani, T. Miyawaki, M. Funahashi, H. Higuchi, R. Matsuo, and M. Shimada, “Ketamine and midazolam differentially inhibit nonadrenergic noncholinergic lower esophageal sphincter relaxation in rabbits: role of superoxide anion and nitric oxide synthase,” Anesthesiology, vol. 98, no. 2, pp. 449–458, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. F. C. C. da Silva, M. do Carmo de Oliveira Cito, M. I. G. da Silva et al., “Behavioral alterations and pro-oxidant effect of a single ketamine administration to mice,” Brain Research Bulletin, vol. 83, no. 1-2, pp. 9–15, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. L. de Oliveira, C. M. dos S. Spiazzi, T. Bortolin et al., “Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 33, no. 6, pp. 1003–1008, 2009. View at Publisher · View at Google Scholar · View at PubMed
  41. S. A. Lipton, “Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond,” Nature Reviews Drug Discovery, vol. 5, no. 2, pp. 160–170, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. B. Sinner and B. M. Graf, “Ketamine,” Handbook of experimental pharmacology, no. 182, pp. 313–333, 2008. View at Google Scholar · View at Scopus
  43. R. Kortekaas, R. P. Maguire, A. van Waarde, K. L. Leenders, and P. H. Elsinga, “Despite irreversible binding, PET tracer [11C]-SA5845 is suitable for imaging of drug competition at sigma receptors—the cases of ketamine and haloperidol,” Neurochemistry International, vol. 53, no. 1-2, pp. 45–50, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. L. A. Reinke, Y. Kotake, D. R. Moore, and A. A. Nanji, “Free radical formation during ketamine anesthesia in rats: a cautionary note,” Free Radical Biology and Medicine, vol. 24, no. 6, pp. 1002–1006, 1998. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Kovacic, “Role of oxidative metabolites of cocaine in toxicity and addiction: oxidative stress and electron transfer,” Medical Hypotheses, vol. 64, no. 2, pp. 350–356, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. K. N. Kirschner, C. Van Dyke, P. Kovacic, and J. P. Bowen, “Computational studies on electron transfer by the iminium metabolite of phencyclidine (PCP),” Journal of Molecular Structure: THEOCHEM, vol. 498, pp. 167–179, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. P. Kovacic and R. Somanathan, “Clinical physiology and mechanism of dizocilpine (MK-801): electron transfer, radicals, redox metabolites and bioactivity,” Oxidative Medicine and Cellular Longevity, vol. 3, no. 1, pp. 13–22, 2010. View at Google Scholar · View at Scopus
  48. D. E. Emmanouil and R. M. Quock, “Advances in understanding the actions of nitrous oxide,” Anesthesia progress, vol. 54, no. 1, pp. 9–18, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. J. D. Jacintho and P. Kovacic, “Neurotransmission and neurotoxicity by nitric oxide, catecholamines, and Glutamate: unifying themes of reactive oxygen species and electron transfer,” Current Medicinal Chemistry, vol. 10, no. 24, pp. 2693–2703, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. P. Kovacic and R. Somanathan, “Integrated approach to nitric oxide in animals and plants (mechanism and bioactivity): cell signaling and radicals,” Journal of Receptors and Signal Transduction, vol. 31, no. 2, pp. 111–120, 2011. View at Publisher · View at Google Scholar · View at PubMed
  51. E. Tydén, H. Tjälve, and P. Larsson, “Metabolic activation of 2,6-xylidine in the nasal olfactory mucosa and the mucosa of the upper alimentary and respiratory tracts in rats,” Toxicological Sciences, vol. 81, no. 2, pp. 263–272, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. J. Thomas and P. Meffin, “Aromatic hydroxylation of lidocaine and mepivacaine in rats and humans,” Journal of Medicinal Chemistry, vol. 15, no. 10, pp. 1046–1049, 1972. View at Google Scholar · View at Scopus
  53. D. Jackson, A. H. Chen, and C. R. Bennett, “Identifying true lidocaine allergy,” The Journal of the American Dental Association, vol. 125, no. 10, pp. 1362–1366, 1994. View at Google Scholar · View at Scopus
  54. C. J. Park, S. A. Park, T. G. Yoon, S. J. Lee, K. W. Yum, and H. J. Kim, “Bupivacaine induces apoptosis via ROS in the Schwann cell line,” Journal of Dental Research, vol. 84, no. 9, pp. 852–857, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. K. Nouette-Gaulain, C. Jose, X. Capdevila, and R. Rossignol, “From analgesia to myopathy: when local anesthetics impair the mitochondrion,” International Journal of Biochemistry and Cell Biology, vol. 43, no. 1, pp. 14–19, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. O. Galbes, A. Bourret, K. Nouette-Gaulain et al., “N-acetylcysteine protects against bupivacaine-induced myotoxicity caused by oxidative and sarcoplasmic reticulum stress in human skeletal myotubes,” Anesthesiology, vol. 113, no. 3, pp. 560–569, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. J. M. Dippenaar, “Local anesthetic toxicity,” SAJAA, vol. 13, pp. 23–28, 2007. View at Google Scholar
  58. C. H. Kindler and C. S. Yost, “Two-pore domain potassium channels: new sites of local anesthetic action and toxicity,” Regional Anesthesia and Pain Medicine, vol. 30, no. 3, pp. 260–274, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. M. E. Johnson, J. C. Sill, C. B. Uhl, T. J. Halsey, and G. J. Gores, “Effect of volatile anesthetics on hydrogen peroxide-induced injury in aortic and pulmonary arterial endothelial cells,” Anesthesiology, vol. 84, no. 1, pp. 103–116, 1996. View at Publisher · View at Google Scholar · View at Scopus
  60. H. Türkan, A. Aydin, and A. Sayal, “Effect of volatile anesthetics on oxidative stress due to occupational exposure,” World Journal of Surgery, vol. 29, no. 4, pp. 540–542, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  61. L. G. Kevin, E. Novalija, and D. F. Stowe, “Reactive oxygen species is mediators of cardiac injury and protection: the relevance to anesthesia practice,” Anesthesia and Analgesia, vol. 101, no. 5, pp. 1275–1287, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. E. Novalija, L. G. Kevin, B. S. Henry, H. B. S. Eells, and D. F. Stowe, “Anesthetic preconditioning triggered by reactive oxygen species improves mitochondrial function after ischemia,” Anesthesiology, vol. 95, abstract A104, 2001. View at Google Scholar
  63. P. T. Liu, P. A. Kentish, A. M. Symons, and D. V. Parke, “The effects of ether anaesthesia on oxidative stress in rats—dose response,” Toxicology, vol. 80, no. 1, pp. 37–49, 1993. View at Google Scholar · View at Scopus
  64. S. Lemoine, C. Buléon, R. Rouet et al., “Bradykinin and adenosine receptors mediate desflurane induced postconditioning in human myocardium: role of reactive oxygen species,” BMC Anesthesiology, vol. 10, article no. 12, 2010. View at Publisher · View at Google Scholar · View at PubMed
  65. S. G. De Hert, S. Cromheecke, P. W. Ten Broecke et al., “Effects of propofol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients,” Anesthesiology, vol. 99, no. 2, pp. 314–323, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. R. R. Lamberts, G. Onderwater, N. Hamdani et al., “Reactive oxygen species-induced stimulation of 5'amp-activated protein kinase mediates sevoflurane-induced cardioprotection,” Circulation, vol. 120, no. 1, pp. S10–S15, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. K. Tanaka, D. Weihrauch, L. M. Ludwig, J. R. Kersten, P. S. Pagel, and D. C. Warltier, “Mitochondrial adenosine triphosphate-regulated potassium channel opening acts as a trigger for isoflurane-induced preconditioning by generating reactive oxygen species,” Anesthesiology, vol. 98, no. 4, pp. 935–943, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. K. Tanaka, L. M. Ludwig, J. R. Kersten, P. S. Pagel, and D. C. Warltier, “Mechanisms of cardioprotection by volatile anesthetics,” Anesthesiology, vol. 100, no. 3, pp. 707–721, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. F. Sedlic, D. Pravdic, M. Ljubkovic, J. Marinovic, A. Stadnicka, and Z. J. Bosnjak, “Differences in production of reactive oxygen species and mitochondrial uncoupling as events in the preconditioning signaling cascade between desflurane and servoflurane,” Anesthesia & Analgesia, vol. 109, pp. 405–411, 2009. View at Google Scholar
  70. F. Eroglu, L. Yavuz, B. G. Ceylan et al., “New volatile anesthetic, desflurane, reduces vitamin e level in blood of operative patients via oxidative stress,” Cell Biochemistry and Function, vol. 28, no. 3, pp. 211–216, 2010. View at Publisher · View at Google Scholar · View at PubMed
  71. E. Novalija, L. G. Kevin, A. K. S. Camara, Z. J. Bosnjak, J. P. Kampine, and D. F. Stowe, “Reactive oxygen species precede the ε isoform of protein kinase C in the anesthetic preconditioning signaling cascade,” Anesthesiology, vol. 99, no. 2, pp. 421–428, 2003. View at Publisher · View at Google Scholar · View at Scopus
  72. H. Türkan, A. Aydin, A. Sayal, A. Eken, C. Akay, and B. Karahalil, “Oxidative and antioxidative effects of desflurane and sevoflurane on rat tissue in vivo,” Arhiv za Higijenu Rada i Toksikologiju, vol. 62, no. 2, pp. 113–119, 2011. View at Publisher · View at Google Scholar · View at PubMed
  73. K. G. Karageuzyan, “Halothane anesthesis in oxidative stress,” in the International Symposium on the Application of the Theory of Metabolic Regulation to Pain, pp. 330–334, Stepanakert, Azerbaijan, 1998.
  74. A. Yesilkaya, Z. Ertug, Yegin, M. Melikoglu, and O. K. Baskurt, “Deformability and oxidant stress in red blood cells under the influence of halothane and isoflurane anesthesia,” General Pharmacology, vol. 31, no. 1, pp. 33–36, 1998. View at Publisher · View at Google Scholar · View at Scopus
  75. E. A. El-Bassiouni, M. M. Abo-Ollo, M. H. Helmy, S. Ismail, and M. I. A. Ramadan, “Changes in the defense against free radicals in the liver and plasma of the dog during hypoxia and/or halothane anaesthesia,” Toxicology, vol. 128, no. 1, pp. 25–34, 1998. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Yesilkaya and P. Dogan, “Halothane induced lipid peroxidation on human erythrocyte membranes,” Turkish Journal of Medical Sciences, vol. 16, no. 4, pp. 275–280, 1992. View at Google Scholar
  77. C. Wang, X. Zhang, F. Liu, M. G. Paule, and W. Slikker, “Anesthetic-induced oxidative stress and potential protection,” TheScientificWorldJournal, vol. 10, pp. 1473–1482, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  78. B. G. Ceylan, F. Yilmaz, F. Eroglu, L. Yavuz, S. Gulmen, and H. Vural, “Oxidant and antixidant activities of different anesthetic techniques. Propofol versus desflurance,” Saudi Medical Journal, vol. 30, no. 3, pp. 371–376, 2009. View at Google Scholar
  79. Z. Peng, M. Luo, S. Ye, G. Joynt, and L. Critchley, “The protective effects of propofol on vascular endothelial cells,” Anesthesiology, vol. 96, abstract A58, 2002. View at Google Scholar
  80. I. V. Balyasnikova, D. E. Schwartz, V. L. Baughman, W. E. Hoffman, and S. M. Danilov, “Protective effect of propofol on reperfusion-induced lung microvascular injury,” Anesthesiology, vol. 96, abstract A49, 2002. View at Google Scholar
  81. M. Şişecioǧlu, M. Çankaya, I. Gülçin, and H. Özdemir, “The inhibitory effect of propofol on bovine lactoperoxidase,” Protein and Peptide Letters, vol. 16, no. 1, pp. 46–49, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. M. W. Anders, “Formation and toxicity of anesthetic degradation products,” Annual Review of Pharmacology and Toxicology, vol. 45, pp. 147–176, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  83. B. A. Gentz and T. P. Malan Jr., “Renal toxicity with sevoflurane: a storm in a teacup?” Drugs, vol. 61, no. 15, pp. 2155–2162, 2001. View at Google Scholar · View at Scopus
  84. H. Bito, “Metabolism and toxicity of anesthetics,” Japanese Journal of Anesthesiology, vol. 48, pp. S172–S179, 1999. View at Google Scholar · View at Scopus
  85. J. D. Levitt, “The biochemical basis of anesthetic toxicity,” Surgical Clinics of North America, vol. 55, no. 4, pp. 801–818, 1975. View at Google Scholar · View at Scopus
  86. B. Cox, M. E. Durieux, and M. A. Marcus, “Toxicity of local anesthetics,” Best Practice & Research Clinical Anaesthesiology, vol. 17, pp. 111–136, 2003. View at Google Scholar
  87. J. G. Kenna and R. M. Jones, “The organ toxicity of inhaled anesthetics,” Anesthesia and Analgesia, vol. 81, no. 6, pp. S51–S66, 1995. View at Google Scholar · View at Scopus
  88. P. Kovacic, R. S. Pozos, and C. D. Draskovich, “Unifying electrostatic mechanism for receptor-ligand activity,” Journal of Receptors and Signal Transduction, vol. 27, no. 5-6, pp. 411–431, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus